Travere Therapeutic | 4:持股变动声明-董事 Poole Sandra
Travere Therapeutic | 4:持股变动声明-董事 Williams Brinkley Ruth
Travere Therapeutic | 4:持股变动声明-董事 Squarer Ron
Travere Therapeutic | 4:持股变动声明-董事 COUGHLIN TIMOTHY
Travere Therapeutic | 4:持股变动声明-董事 LYONS GARY A
Travere Therapeutic | 4:持股变动声明-董事 Meckler Jeffrey A
Travere Therapeutic | 4:持股变动声明-董事 Baynes Roy D.
Travere Therapeutic | 4:持股变动声明-董事 Bruhn Suzanne Louise
Travere Therapeutic | SC 13G:超过5%持股股东披露文件-Rock Springs Capital Management LP(5.79%),Rock Springs Capital LLC(5.79%)等
Travere Therapeutic | 4:持股变动声明-高管 Cline Christopher R.
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.83%),Steven Boyd(9.83%)
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%)等
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-Macquarie Group Limited(6.31%),Macquarie Management Holdings Inc(6.31%)等
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.34%)
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(0.0%)
Travere Therapeutic | SC 13G:超过5%持股股东披露文件-Morgan Stanley(5.5%)
Travere Therapeutic | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Partners, L.P.(0.67%),Adage Capital Partners GP, L.L.C.(0.67%)等
Travere Therapeutic | 4:持股变动声明-高管 Dube Eric M
Travere Therapeutic | 4:持股变动声明-高管 ROTE WILLIAM E.
Travere Therapeutic | 4:持股变动声明-高管 Calvin Sandra
暂无数据